Tianshui Zhongxing Bio-technology Co.,Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 858.78 million compared to CNY 704.36 million a year ago. Revenue was CNY 858.78 million compared to CNY 704.36 million a year ago.

Net loss was CNY 20.03 million compared to net income of CNY 12.53 million a year ago. Basic loss per share from continuing operations was CNY 0.0517 compared to basic earnings per share from continuing operations of CNY 0.0354 a year ago. Diluted loss per share from continuing operations was CNY 0.0517 compared to diluted earnings per share from continuing operations of CNY 0.0354 a year ago.